Phase 2 Coronary atherosclerosis Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Terminated
Phase 2
Can Semaglutide or empagliflozin stabilise coronary atherosclerosis in people with type 2 diabetes after acute coronary syndrome
Coronary atherosclerosis
South Australian Health and Medical Research Institute132 enrolled1 locationACTRN12623000661673
Recruiting
Phase 2Phase 3
Do stAtins faVourably modify atherosclerotIc plaque in patients with differeNt levels of polygenic Cardiovascular (CV) rIsk?
Coronary atherosclerosisPolygenic risk
Monash University600 enrolled6 locationsACTRN12620001166965